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Abstract 
Pleckstrin is a 40 kDa substrate for protein kinase C found in platelets and neutrophils. Based upon its sequence, 
pleckstrin contains two of the recently-described PH domains that are thought o be binding motifs for phosphatidyl 
4,5-bisphosphate (PIP 2) and/or G protein /33' heterodimers (G~v). In the present studies we have examined the interaction 
between pleckstrin and G~ by incubating pleckstrin fusion proteins with lysates from human platelets. In this analysis, both 
the N-terminal and C-terminal PH domains from pleckstrin bound G~v in vitro, as did peptides containing as little as the 
first 30 residues of the C-terminal pleckstrin PH domain. Introduction of a point mutation into this region, analogous to the 
mutation in the Btk PH domain that causes X-linked immunodeficiency disease (XID) in mice, dramatically disrupted this 
interaction. We propose that pleckstrin may interact with G~, and that one potential site for this interaction involves the 
first 30 residues of pleckstfin's C-terminal PH domain. 
Keywords: Pleckstrin; Plecksl~rin homology domain; G protein; Platelet signaling 
I. Introduction 
Human platelets are able to play a critical role in 
hemostasis in part because of an intracellular signal- 
ing process that involves receptor-mediated activation 
of cytoplasmic enzymes uch as phospholipase C and 
protein kinase C, leading to cytoskeletal reorganiza- 
Abbreviations: PH, pleckstrin homology; GST, glutathione-S- 
transferase; G/3 v, /3T-subunits of heterotrimeric G proteins; Btk, 
Bruton's tyrosine kinase; PKC, protein kinase C; XID, X-linked 
immunodeficiency 
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tion, fibrinogen receptor exposure, aggregation and 
secretion. To better understand the molecular basis 
for these events, we have continued our studies on 
the role of pleckstrin, a prominent substrate in 
platelets for protein kinase C. Pleckstrin was cloned 
in 1988 [1], but its function remained elusive until 
recently when it was noted that the first and last 100 
residues of pleckstrin are homologous with a number 
of proteins that play a role in cellular signaling [2-6]. 
Since the homology between these proteins was first 
noted in sequence comparisons with pleckstrin, the 
involved regions are commonly termed 'pleckstrin 
homology' or PH domains. Within the past year 
essentially identical three-dimensional structures were 
reported for the PH domains from /3-spectrin, dy- 
namin, phospholipase C 8 and the N-terminus of 
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pleckstrin, supporting their status as a bona fide 
structural motif [7-13]. 
Over seventy proteins other than pleckstrin have 
now been shown to contain PH domains, including 
rac-PK, ras-GAP, ras-GRF, Sos, SEC7, OSBP, Nrk 
A, Btk, /3ARK, spectrin, dynamin, phospholipase C 
(/3, y, and 6), 3BP2, unc-104, Grb7, and Bern3 
[2-5]. A striking feature of this list is that many of 
the proteins: (1) are known signal transducers and 
proto-oncogenes, and (2) appear to be membrane 
associated. Although it is generally believed that PH 
domains will turn out to mediate intermolecular inter- 
actions and may be involved in membrane targeting, 
there is as yet no consensus on the specifics of this 
interaction. Both phosphatidylinositol 4,5-bisphos- 
phate (PIP 2) [14] and G~ [4,15-17] have been pro- 
posed as potential partners for PH domains, and there 
is evidence for both. In a previous report, we have 
shown that when transfected into Cos-1 and HEK-293 
cells, pleckstrin can inhibit agonist-induced phospho- 
inositide hydrolysis mediated by a variety of G pro- 
tein-coupled receptors, including those that activate 
phospholipase C via G~ [18]. However, pleckstrin 
was also found to inhibit the stimulation of phospho- 
inositide hydrolysis caused by a constitutively-active 
form of Gqa and by the receptor tyrosine kinase, 
TrkA, and had no effect on the regulation of cAMP 
formation by adenylyl cyclase [18]. The inhibition of 
phosphoinositide hydrolysis required an intact N- 
terminal PH domain and was additive with that ob- 
served when cells lacking pleckstrin were preincu- 
bated briefly with PMA, suggesting that it is indepen- 
dent of the PMA-induced phosphorylation of recep- 
tors, G proteins and phospholipase C that has been 
reported by others [19-22]. Phosphorylation of pleck- 
strin at Ser 1~3, Thr 114 and Ser 117 was required for 
maximal inhibitory effect [23]. These results sug- 
gested that pleckstrin may interfere with the interac- 
tion of phospholipase C with PIP 2, perhaps participat- 
ing in the feedback regulation of phosphoinositide 
hydrolysis following activation of protein kinase C. 
Although, our previous studies have indicated a 
likely effect of pleckstrin on PIP2-mediated signaling, 
other investigators have demonstrated an interaction 
between PH domains and G~ heterodimers. The 
argument hat PH domains are sites for interaction 
with G~ rests upon the observations that: (1) some 
G~-regulated proteins contain PH domains, (2) PH 
domain-containing fusion proteins adhere to G~ in 
vitro, and (3) PH domain-containing peptides can 
inhibit G~-dependent signaling events [16,17,24,25]. 
The protein for which these issues have been ex- 
plored in the greatest detail is the G protein-coupled 
receptor kinase, /3ARK1, which is activated by Gt3 v. 
The domain necessary for this activation overlaps 
with the C-terminal half of the /3ARK1 PH domain, 
and peptides containing the /3ARK1 PH domain have 
been shown to inhibit phospholipase C, adenylate 
cyclase and MAP kinase activation [25,25,26]. The 
/3ARK1 PH domain has also been shown to bind Gt3 ~ 
[16] and to directly associate with PIP 2 [14]. 
In the present studies we have examined whether 
either of the two PH domains from pleckstrin can 
associate with Gt~  in a fashion analogous to other 
PH domain containing proteins. We have also mapped 
the regions necessary for this interaction. The results 
show that: (1) both the N-terminal and the C-terminal 
PH domains from pleckstrin can associate with Gt~  
in vitro, (2) this association can be mediated by a 
region as short as the first 30 amino acids of the 
C-terminal PH domain, and (3) a point mutation 
analogous to the mutation in the PH domain of Btk 
found in mice with X-linked immunodeficiency dis- 
ease (XID) abrogates this interaction. Based upon 
these results and our earlier findings [18], we suggest 
that pleckstrin, working through its two prototypical 
PH domains, interacts with G~ heterodimers a  well 
as PIP2 and may as a result play an important role in 
G protein-dependent signaling in platelets. 
2. Methods 
2.1. Construction of GST expression vectors and GST 
fusion proteins 
DNA fragments encoding pleckstrin PH domains 
were generated by RT-PCR from HL60 mRNA with 
the following primers: GST-Pleckstrin (6-99): ggcg- 
gc ggatccatcagagagggctacctt and ggcgg caattg ttaggc- 
cttattgatatcccg, GST-Pleckstrin (246-345): ggcgcc g- 
gatccatcaagcagggatgtttac nd ggcgcgaattcttaggc- 
catctggatggcttt, GST-Pleckstrin (6-35): ggcggcg- 
gatccatcagagagggctacctt and ggcggcaattgt ta -  
gaattcaattccatcttc, GST-Pleckstrin (36-69): ggcggc g- 
gatcctataagaagaaaagtgacaac and ggcgg caattg ttaaaa- 
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cacaaacatcctttt, GST-Pleckstrin (70-99): ggcggcg- 
gatccaagatcactacgaccaaa nd ggcgg caattgttaggcct- 
tattgatatcccg, GST-Pleckstrin (246-345): ggcgccg- 
gatccatcaagcagggatgtttac and ggcgcgaattcttaggc- 
catctggatggcttt, GST-Pleckstrin (246-275): ggcgcc g- 
gatccatcaagcagggatgtttac .andggcgg caang ttacaggtag- 
gcagggtcttc, GST-Pleckstrin (276-315): ggcggcg- 
gatcccactactatgaccctgct and ggcgg caattg ttaaaaaag- 
gttctcttcctc, GST-Pleckslxin (316-345): ggcggcg- 
gatccgagatcatcacagcagat and ggcgcgaattcttaggc- 
catctggatggcttt. Each primer encoded restriction sites 
(italics) that incorporated a BamHI site at the 5' end 
and an EcoRI or MunI site at the 3' end of each PCR 
product. The cDNA fragments were digested with the 
appropriate restriction enzyme, ligated into BamHI 
and EcoRI digested PGEX-2T (Pharmacia), a plas- 
mid that encodes for a 27 kDa glutathione S-trans- 
ferase (GST) protein. DNA encoding the GST- 
Pleckstrin (246-275) ArgZ64-Cys was generated by 
the technique of Landt et al. [27] using the mutagene- 
sis primers: ggaaagtgtgcaagttcatcttgaga. The cloned 
cDNA sequences were all confirmed. Wild type GST 
and GST fusion proteins were expressed in E. coli 
and then coupled to glutathione-covered agarose beads 
[28]. Approximately equal amounts of fusion proteins 
were used for each adsorption as quantitated by 
Coomassie Brilliant Blue-R staining of SDS-PAGE 
gels. 
2.2. Gt~  capture assay 
Human platelets isolated by differential centrifuga- 
tion from blood anticoagulated with 15% acid citrate 
dextrose (63 mM sodium c i t ra te / I l l  mM 
dextrose/71 mM citric acid) were washed in 
Hepes/tyrode buffer (129 mM NaC1/8.9 mM 
NaHCO3/2.8 mM KC1/0.8 mM KH2PO4/56 mM 
dextrose/10 mM Hepes, pH 7.4/0.8 mM MgC12) 
with 1 mM PGE1.3.3 × 108 resting, washed platelets 
were lysed in 1% cholate/5 mM MgC12/50 mM 
Hepes, pH 8/1 mM EDTA/1 mM PMSF/0.1% 
aprotinin/50 /zg per ml leupeptin/1 mM vanadate. 
The clarified lysates were incubated overnight with 
glutathione agarose beads coupled with 10 /.Lg of 
GST fusion proteins. The beads and associated pro- 
teins were washed in lysis buffer, electrophoresed, 
and immunoblotted tbr G~ (DuPont anti-Gt~ 
#NEI808). 
3. Results and discussion 
3.1. Recombinant PH domains from pleckstrin asso- 
ciate with Gt~  heterodimers from platelet lysates 
As shown in Fig. 1, pleckstrin is composed of 350 
amino acids, the first and last 100 comprising the two 
PH domains [1]. The intervening 150 residues include 
the three principal sites for phosphorylation by pro- 
tein kinase C (PKC): Ser 113, Thr  114 and Ser ll7 [23]. 
To address the role of pleckstrin's PH domains, we 
synthesized both of the pleckstrin PH domains as 
glutathione-S-transferase (GST) fusion proteins, cou- 
pled them to glutathione-covered agarose beads and 
incubated them with platelet lysates. After extensive 
washing, retention of the Gt3 r complex on the beads 
was assessed by immunoblotting with an anti-Gt3 
antibody (Fig. 2A). Under these conditions, Gt~ r asso- 
ciated prominently and consistently with the C-termi- 
nal PH domain (residues 246-345) and somewhat 
less prominently with the N-terminal PH domain 
(residues 6-99). In contrast, G~r did not associate at 
all with either GST alone or a fusion protein contain- 
ing the SH2 domain from RasGAP (not shown). 
Results similar to these were obtained in seven exper- 
iments using three different anti-Gt3 antibodies, 
demonstrating that, in vitro, that the PH domains of 
pleckstrin, like the homologous region of /3ARK1 
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Fig. 1. Structure ofpleckstrin and GST fusion proteins. Schematic 
showing the locations of the N- and C-terminal PH (pleckstrin 
homology) domains, Arg 264 and the GST fusion proteins used in 
these studies. The . . . . .  represents the three principal sites of 
pleckstrin phosphorylation: SerI~3, Thr 114 and Ser j17. 
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Fig. 2. Gt3 immunoblot fplatelet proteins associated with GST 
fusion proteins. In (A) and (B) glutathione beads coated with 
either GST or the GST fusion proteins hown were incubated 
with platelet lysate, washed and then immunoblotted for G~. The 
results how that G~ associates with intact N- or C-terminal PH 
fusion proteins, and a fusion protein containing the first 30 
residues of the C-terminal PH domain. 
[16] and other proteins including Btk, PLC~ and 
/3-spectrin [16], are able to associate with Gt~ . 
3.2. The first third of the C-terminal PH domain from 
pleckstrin contains a site of interaction with Gt~  
heterodimers 
To further localize regions in the pleckstrin PH 
domains that can interact with G~r, we prepared six 
additional GST fusion proteins, each corresponding 
to approx, one-third of the two pleckstrin PH do- 
mains (Fig. 2B). Of the polypeptides tested, only the 
one corresponding to the first 30 amino acids of the 
C-terminal PH domain bound Gt~ r from platelet 
lysates. 
Previously, it has been demonstrated that G,~ dis- 
sociates from G~r upon platelet activation by an 
agonist or after incubation of platelet lysates with 
nonhydrolyzable GTP analogs, such as GTPTS [29]. 
To test whether association with G~ affects the inter- 
action between Gt~ r and the pleckstrin PH domains, 
the C-terminal PH domain fusion protein (residues 
246-345) was incubated with either lysates prepared 
from thrombin-treated platelets or lysates to which 
0.2 mM GTPTS was added. Neither activation of the 
platelet thrombin receptors nor the presence of GTPy S 
affected the association of Gt~ with the fusion protein 
(not shown). 
These results suggest, first, that a major site of 
interaction between G~r and pleckstrin is in the first 
third of the C-terminal PH domain and, second, that 
under these conditions the association of Get with G~ 
may not affect the pleckstrin:Gt~ r interaction. These 
findings contrast with the suggestion that the contact 
between G¢~ and /3ARK1 involves the distal, rather 
than proximal, portion of the /3ARK1 PH domain, 
and that G, and the /3ARK1 PH domain compete for 
binding to Gt~ r [16]. These differences between 
/3ARK1 and pleckstrin could simply reflect differ- 
ences between various PH-domain-containing pro- 
teins, or could be due to the presence of multiple sites 
of interaction between PH domain and G~r. 
3.3. A single point mutation inhibits the interaction 
between a pleckstrin PH domain and Gt~  
Previously, it has been noted that a mutation in the 
pleckstrin homology domain in Bruton's tyrosine ki- 
nase, Btk, creates the XID phenotype in mice [5,30]. 
This arginine to cysteine mutation is located at the 
nineteenth residue of the PH domain, and is immedi- 
ately distal to an extremely variable of pleckstrin 
homology domains. We compared the amino acid 
sequence of the first thirty residues of the PH do- 
mains in Btk with the N-terminal and C-terminal PH 
domains in pleckstrin (Fig. 3). The alignment shows 
a greater similarity between the C-terminal pleckstrin 
PH domain and Btk than between the N-terminal PH 
domain and Btk. We therefore tested whether a corre- 
sponding arginine to cysteine mutation in the C- 
terminal PH domain would affect the association with 
Gt~ r by creating an Arg264-Cys variant of the GST 
fusion protein containing the first 30 residues of the 
P lecks t r in  (6 -35)  IREGYLVKKGSVF . . . . .  NTWIPMWVVLLEDGIEF  
• : . • : °  .5  .5  . . 
Btk  (5 -39)  I LES IFLKRSQQKI~XTSPLNFXRLFLLTV I~LSY  
: ° ° : :  , ° : .~ ~ 5.5 
P lecks t r in  (246-275)  IKQGCLLKQG~R . . . . .  K I~C~RKF I~PAYL  
Plec~trln Arg 264 
Fig. 3. Alignment of the first 30 amino acids of the PH domains 
from Btk and pleckstrin. ':' denotes identical residues. '.' denotes 
similar residues with a score of 0.7 or higher on the Dayhoff 
scale [34]. 
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Fig. 4. G~ immunoblot of platelet proteins associated with pleck- 
strin variant GST fusion proteins. Glutathione beads coated with 
either GST or the GST fusion proteins shown were incubated 
with platelet lysate, washed and then immunoblotted for G~. The 
results show that G~ associates with fusion proteins containing 
the first 30 residues of the C-terminal PH domain and that this 
association can be disrupted bl¢ the R264 C pleckstrin mutation. 
pleckstrin C-terminal PH domain. The results show 
that the mutated pleckstrin PH domain is dramatically 
less effective than the wild type in binding G~r from 
platelet lysates (Fig. 4). 
3.4. Conclusion 
Pleckstrin was originally identified as 'p47', a 
prominent platelet substrate for protein kinase C that 
was shown to become phosphorylated onboth serine 
and threonine residues in response to thrombin and 
PMA [31,32]. The identification of the homologous 
ends of pleckstrin as the prototypes for a structural 
motif that is present in a large number of signaling 
molecules uggests that pleckstrin may also play a 
role in cell signaling. It has only been recently that a 
possible role for pleckstrin has been defined. The 
observations in this current study support he pro- 
posal that PH domains interact with G/3 r [16], while 
suggesting that one likely contact point with G~ lies 
within the first 30 amino acids of the C-terminal PH 
domain. Furthermore, the results show that at least 
one specific mutation, analogous to that found in Btk 
in XID mice, inhibits the association of pleckstrin's 
C-terminal PH domain with G~ in vitro. Although 
these observations and conclusion focus on G~r, they 
do not exclude an additional interaction between 
pleckstrin and PIP 2. Notably, however, the results of 
our previous studies show that, when expressed in 
Cos-1 cells, pleckstrin inhibits phosphoinositide hy- 
drolysis irrespective of whether the C-terminal PH 
domain (but not the N-terminal PH domain) has been 
deleted [18]. Since the inhibition observed in that 
system appeared to be due to an interaction of pleck- 
strin with PIP 2, rather than G~, it is possible that the 
C-terminal PH domain prefers G~r, while the N- 
terminal PH domain prefers to interact with PIP 2. If 
so, this would suggest hat the two PH domains in 
pleckstrin serve different functions. 
Lefkowitz and coworkers have mapped another 
G~r binding region to the distal (a-helical) region of 
the /3ARK1 PH domain [16]. The region that they 
implicated in G~r binding extends to residues car- 
boxyl to the /3ARK1 PH domain, and is dependent 
on the dissociation of the G/3 r heterodimers from G,,. 
Their finding are in contrast o our work on the 
pleckstrin PH domains, which suggest a contact point 
in the proximal portion of the pleckstrin C-terminal 
PH domain which is independent of G,. It is likely 
that there are multiple contacts points between G~r 
and PH domains, and the results of the Lefkowitz 
study and our own work have only given insight into 
a few of the necessary sites of association. 
To date, /3ARK1 is the only PH containing protein 
known to directly associate with G~r in vivo, al- 
though a recent study has shown that Btk and a 
related tyrosine kinase, Tsk, are stimulated by G~ 
[33]. Previous investigators have shown that overex- 
pression of some, but not all, PH domains within 
Cos-1 cells can inhibit G~r mediated phosphoinosi- 
tide hydrolysis [17,25], much as we have shown to be 
the case for full length pleckstrin [18]. However, 
pleckstrin does not inhibit G~r-mediated cAMP stim- 
ulation or inhibition [18]. Recently, we have found 
that in vitro, full length recombinant phospho- 
pleckstrin inhibits the phosphorylation f PIP 2 by the 
G~r-activatable isoform of PI-3 kinase, while having 
no apparent effect on the growth factor activatable 
(p85-associated) PI-3 kinases whose activation is in- 
dependent of G~r [35]. In addition, the pleckstrin-in- 
hibitory effects on PI3K7 were overcome by compe- 
tition from increasing amounts of G~r. This suggests 
that some pleckstrin effects may be specific for G~r. 
However, it is still remains to be demonstrated 
whether pleckstrin mediates this effect through a 
direct association with G~r in vivo, and whether 
pleckstrin has this effect in cells that endogenously 
238 C.S. Abrams et al. / Biochimica et Biophysica Acta 1314 (1996) 233-238 
contain these proteins, such as platelets and leuko- 
cytes. 
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